Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults

References

• Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010;10:67
   PubMed Web of Science ®Google Scholar
• Faraone S V, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006;36:159-65
   PubMed Web of Science ®Google Scholar
• Barkley RA, Peters H. The earliest reference to ADHD in the medical literature? Melchior Adam Weikard’s description in 1775 of “attention deficit” (mangel der aufmerksamkeit, attentio volubilis). J Atten Disord 2012;16:623-630.
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Montoya A, Kutzelnigg A, et al. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 2013;29(9):1093-104
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-8
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Addalli KA. Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1991;30:743-51
   PubMed Web of Science ®Google Scholar
• Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323:1361-6
   PubMed Web of Science ®Google Scholar
• Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 1996;37:393-401
   PubMed Web of Science ®Google Scholar
• Barkley R, Murphy KV, Fischer M. ADHD in adults, What the Science Says. Guilford Press; NY, USA
   Google Scholar
• Spencer T, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995;52(6):434-43
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1998;155(5):693-5
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005;57:1442-51
   PubMed Web of Science ®Google Scholar
• Spence D. Bad medicine: adult attention-deficit/hyperactivity disorder. BMJ 2011;343(343):d7244
   Google Scholar
• Moncrieff J, Timimi S. Is ADHD a valid diagnosis in adults? No. BMJ 2010;26(340):c547
   Google Scholar
• Thomas R, Mitchell GK, Batstra L. Attention-deficit/ hyperactivity disorder: are we helping or harming? BMJ 2013;6172:1-7
   Google Scholar
• Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-23
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. Community Pract 2009;82(10):34-7
   Google Scholar
• McCarthy S, Asherson P, Coghill D, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009;194(3):273-7
   PubMed Web of Science ®Google Scholar
• Aragonès E, Lluís Piñol J, Ramos-Quiroga JA, et al. Prevalence in adults of attention deficit hyperactivity disorder using the medical records of primary care. Rev Esp Salud Publica 2006;84:417-22
   Google Scholar
• Shah P, Morton M. Adults with attention deficit hyperactivity disorder – diagnosis or normality? BJP 2013;203:317-19
   Google Scholar
• Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402-9
   PubMed Web of Science ®Google Scholar
• De Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008;65:835-42
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-89
   PubMed Web of Science ®Google Scholar
• Murphy K, Barkley RA. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disord 1996;1:147-61
   Google Scholar
• DuPaul GJ, Schaughency EA, Weyandt LL, et al. Self-report of ADHD symptoms in university students: cross-gender and cross-national prevalence. J Learn Disabil 2001;34(4):370-9
   PubMed Web of Science ®Google Scholar
• Heiligenstein E, Conyers LM, Berns AR, Miller MA. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students. J Am Coll Health 1998;46:185-8
   PubMed Web of Science ®Google Scholar
• Weyandt LL, Linterman I, Rice JA. Reported prevalence of attentional difficulties in a general sample of college students. J Psychopathol Behav Assess 1995;17:293-304
   Web of Science ®Google Scholar
• Kooij JJ, Buitelaar JK, van den Oord EJ, et al. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 2005;35:817-27
   PubMed Web of Science ®Google Scholar
• De Zwaan M, Gruss B, Müller A, et al. The estimated prevalence and correlates of adult ADHD in a German community sample. Eur Arch Psychiatry Clin Neurosci 2012;262:79-86
   PubMed Web of Science ®Google Scholar
• Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194:204-11
   PubMed Web of Science ®Google Scholar
• Michielsen M, Semeijn E, Comijs HC, et al. Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry 2012;201(4):298-305
   PubMed Web of Science ®Google Scholar
• Guldberg-Kjär T, Sehlin S, Johansson B. ADHD symptoms across the lifespan in a population-based Swedish sample aged 65 to 80. Int Psychogeriatr 2013;25:667-75
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, O’Connor KB, et al. Predictors of persistence in girls with attention deficit hyperactivity disorder: results from an 11-year controlled follow-up study. Acta Psychiatr Scand 2012;125:147-56
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Clarke A, et al. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res 2011;45(2):150-5
   PubMed Web of Science ®Google Scholar
• Kotsopoulos N, Connolly MP, Sobanski E, Postma MJ. The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings. J Ment Health Policy Econ 2013;16:27-33
   PubMed Web of Science ®Google Scholar
• Küpper T, Haavik J, Drexler H, et al. The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents. Int Arch Occup Environ Health 2012;85:837-47
   PubMed Web of Science ®Google Scholar
• Almeida Montes LG, Hernández García AO, Ricardo-Garcell J. ADHD prevalence in adult outpatients with nonpsychotic psychiatric illnesses. J Atten Disord 2007;11:150-6
   PubMedGoogle Scholar
• Alpert JE, Maddocks A, Nierenberg AA, et al. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 1996;62:213-19
   PubMed Web of Science ®Google Scholar
• Van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, et al. The International ADHD in substance use disorders prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res 2013;22:232-44
   PubMed Web of Science ®Google Scholar
• Van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012;122:11-19
   PubMed Web of Science ®Google Scholar
• Van de Glind G, Konstenius M, Koeter MWJ, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 2013;132:587-96
   PubMed Web of Science ®Google Scholar
• Tamam L, Karakus G, Ozpoyraz N. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci 2008;258:385-93
   PubMed Web of Science ®Google Scholar
• Philipsen A, Limberger MF, Lieb K, et al. Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry 2008;192:118-23
   PubMed Web of Science ®Google Scholar
• Ferrer M, Andión O, Matalí J, et al. Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder. J Pers Disord 2010;24:812-22
   PubMed Web of Science ®Google Scholar
• Fernández-Aranda F, Agüera Z, Castro R, et al. ADHD symptomatology in eating disorders: a secondary psychopathological measure of severity? BMC Psychiatry 2013;13:166
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Yaqoobi K, et al. Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci 2009;259:98-105
   PubMed Web of Science ®Google Scholar
• Ginsberg Y, Hirvikoski T, Lindefors N. Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry 2010;10(1):112
   PubMed Web of Science ®Google Scholar
• Franke B, Faraone S V, Asherson P, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry 2012;17:960-87
   PubMed Web of Science ®Google Scholar
• Group C, Consortium PG. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013;381(9875):1371-9
   PubMed Web of Science ®Google Scholar
• Ribasés M, Hervás A, Ramos-Quiroga JA, et al. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 2008;63(10):935-45
   PubMed Web of Science ®Google Scholar
• Ribasés M, Ramos-Quiroga JA, Hervás A, et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 2009;14(1):71-85
   PubMed Web of Science ®Google Scholar
• Arcos-Burgos M, Jain M, Acosta MT, et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 2010;15(11):1053-66
   PubMed Web of Science ®Google Scholar
• Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav 2011;10(2):149-57
   PubMed Web of Science ®Google Scholar
• O’Sullivan ML, de Wit J, Savas JN, et al. FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development. Neuron 2012;73:903-10
   PubMed Web of Science ®Google Scholar
• Lesch KP, Merker S, Reif A, Novak M. Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD. Eur Neuropsychopharmacol 2013;23(6):479-91
   PubMed Web of Science ®Google Scholar
• Lange M, Norton W, Coolen M, et al. The ADHD-linked gene Lphn3.1 controls locomotor activity and impulsivity in zebrafish. Mol Psychiatry 2012;17:855-5
   PubMed Web of Science ®Google Scholar
• Wallis D, Hill DS, Mendez IA, et al. Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain Res 2012;1463:85-92
   PubMed Web of Science ®Google Scholar
• Field LL, Shumansky K, Ryan J, et al. Dense-map genome scan for dyslexia supports loci at 4q13, 16p12, 17q22; suggests novel locus at 7q36. Genes Brain Behav 2013;12:56-69
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Picado M, Mallorquí-Bagué N, et al. The neuroanatomy of attention deficit hyperactivity disorder in adults: structural and functional neuroimaging findings. Rev Neurol 2013;56(Suppl 1):S93-106
   Google Scholar
• Cortese S. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 2012;169:1038
   PubMed Web of Science ®Google Scholar
• Cortese S, Imperati D, Zhou J, et al. White matter alterations at 33-year follow-up in adults with childhood attention-deficit/hyperactivity disorder. Biol Psychiatry 2013;74:591-8
   PubMed Web of Science ®Google Scholar
• Proal E, Reiss PT, Klein RG, et al. Brain Gray Matter Deficits at 33-Year Follow-up in Adults With Attention-Deficit/Hyperactivity Disorder Established in Childhood. Arch Gen Psychiatry 2011;68:1122-34
   PubMed Web of Science ®Google Scholar
• Shaw P, Malek M, Watson B, et al. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2013;74:599-606
   PubMed Web of Science ®Google Scholar
• Kooij SJJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010;10:67
   PubMed Web of Science ®Google Scholar
• Charach A, Yeung E, Climans T, Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011;50:9-21
   PubMed Web of Science ®Google Scholar
• Daley D, Birchwood J. ADHD and academic performance: why does ADHD impact on academic performance and what can be done to support ADHD children in the classroom? Child Care Health Dev 2010;36:455-64
   PubMed Web of Science ®Google Scholar
• Chronis AM, Jones HA, Raggi VL. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev 2006;26:486-502
   PubMed Web of Science ®Google Scholar
• Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 2007;37:97-107
   PubMed Web of Science ®Google Scholar
• Amiri S, Ranjbar F, Sadeghi-Bazargani H, et al. Association of adult attention deficit/hyperactivity disorder and traffic injuries in Tabriz – Iran. Iran J Psychiatry 2011;6(2):61-5
   PubMedGoogle Scholar
• Cox DJ, Madaan V, Cox BS. Adult attention-deficit/hyperactivity disorder and driving: why and how to manage it. Curr Psychiatry Rep 2011;13:345-50
   PubMed Web of Science ®Google Scholar
• Vaa T. ADHD and relative risk of accidents in road traffic: a meta-analysis. Accid Anal Prev 2014;62:415-25
   PubMed Web of Science ®Google Scholar
• Redelmeier DA, Chan WK, Lu H. Road trauma in teenage male youth with childhood disruptive behavior disorders: a population based analysis. PLoS Med 2010;7(11):e1000369
   Web of Science ®Google Scholar
• Gudjonsson GH, Sigurdsson JF, Adalsteinsson TF, Young S. The relationship between ADHD symptoms, mood instability, and self-reported offending. J Atten Disord 2013;17(4):339-46
   PubMed Web of Science ®Google Scholar
• Rasmussen K, Almvik R, Levander S. Attention deficit hyperactivity disorder, reading disability, and personality disorders in a prison population. J Am Acad Psychiatry Law 2001;29(2):186-93
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Halldner L, Zetterqvist J, et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 2012;367(21):2006-14
   PubMed Web of Science ®Google Scholar
• Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997;36(9):1211-21
   PubMed Web of Science ®Google Scholar
• Karam RG, Bau CHD, Salgado CAI, et al. Late-onset ADHD in adults: milder, but still dysfunctional. J Psychiatr Res 2009;43:697-701
   PubMed Web of Science ®Google Scholar
• Skirrow C, McLoughlin G, Kuntsi J, Asherson P. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert Rev Neurother 2009;9(4):489-503.
   PubMed Web of Science ®Google Scholar
• Retz W, Stieglitz R-D, Corbisiero S, et al. Emotional dysregulation in adult ADHD: what is the empirical evidence? Expert Rev Neurother 2012;12:1241-51
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Fischer R, et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry 2010;11(5):709-18
   PubMed Web of Science ®Google Scholar
• Regier DA, Narrow WE, Clarke DE, et al. DSM-5 Field Trials in the United States and Canada, Part II: test-Retest Reliability of Selected Categorical Diagnoses. Am J Psychiatry 2013;170:59-70
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Bosch R, Richarte V, et al. Criterion and concurrent validity of Conners adult ADHD diagnostic interview for DSM-IV (CAADID) Spanish version. Rev Psiquiatr y Salud Ment (English Ed) 2012;5:229-35
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Díaz-Digon L, Comín M, et al. Criteria and concurrent validity of adult ADHD section of the psychiatry research interview for substance and mental disorders. J Atten Disord 2012. [Epub ahead of print]
   Google Scholar
• Faraone SV, Spencer T, Aleardi M, et al. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2004;24:24-9
   PubMed Web of Science ®Google Scholar
• Peterson K, McDonagh MS, Fu R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 2008;197(1):1-11
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, et al. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 2009;23(7):733-44
   PubMed Web of Science ®Google Scholar
• Mészáros A, Czobor P, Bálint S, et al. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 2009;12:1137-47
   PubMed Web of Science ®Google Scholar
• Faraone S V, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010;71(6):754-63
   PubMed Web of Science ®Google Scholar
• Castells X, Ramos-Quiroga JA, Rigau D, et al. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 2011;25:157-69
   PubMed Web of Science ®Google Scholar
• Castells X, Ramos-Quiroga JA, Bosch R, et al. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 2011;15(6):CD007813
   Google Scholar
• Maneeton N, Maneeton B, Srisurapanont M, Martin SD. Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials. Psychiatry Clin Neurosci 2011;65:611-17
   PubMed Web of Science ®Google Scholar
• Cunill R, Castells X, Tobias A, Capellà D. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression. Pharmacoepidemiol Drug Saf 2013;22(9):961-9
   PubMed Web of Science ®Google Scholar
• Rösler M, Fischer R, Ammer R, et al. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009;259(2):120-9
   PubMed Web of Science ®Google Scholar
• Upadhyaya H, Ramos-Quiroga JA, Adler LA, et al. Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: a placebo-controlled, randomised withdrawal study. Eur J Psychiatry 2013;27(3):185-205
   Web of Science ®Google Scholar
• Sobanski E, Sabljic D, Alm B, et al. A Randomized, Waiting List-Controlled 12-Week Trial of Atomoxetine in Adults with ADHD. Pharmacopsychiatry 2012;45:100-7
   PubMed Web of Science ®Google Scholar
• Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 2012;10(1):99
   PubMed Web of Science ®Google Scholar
• Surman CBH, Hammerness PG, Pion K, Faraone SV. Do stimulants improve functioning in adults with ADHD? a review of the literature. Eur Neuropsychopharmacol 2013;23:528-33
   PubMed Web of Science ®Google Scholar
• Weisler RH, Pandina GJ, Daly EJ, et al. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. CNS Drugs 2012;26:421-34
   PubMed Web of Science ®Google Scholar
• Ni HC, Shang CY, Gau SS, et al. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2013;16:1959-73
   PubMed Web of Science ®Google Scholar
• Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011;365(20):1896-904
   PubMed Web of Science ®Google Scholar
• Philipsen A. Psychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research. Expert Rev Neurother 2012;12:1217-25
   PubMed Web of Science ®Google Scholar
• Safren SA, Otto MW, Sprich S, et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005;43(7):831-42
   PubMed Web of Science ®Google Scholar
• Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010;304:875-80
   PubMed Web of Science ®Google Scholar
• Virta M, Salakari A, Antila M, et al. Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study. Neuropsychiatr Dis Treat 2010;6:443-53
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Whitmont S, Bornholt L, et al. A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 2002;36(5):610-16
   PubMed Web of Science ®Google Scholar
• Solanto M V, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010;167(8):958-68
   PubMed Web of Science ®Google Scholar
• Weiss M, Murray C, Wasdell M, et al. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry 2012;12:30
   PubMed Web of Science ®Google Scholar
• Emilsson B, Gudjonsson G, Sigurdsson JF, et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry 2011;11(1):116
   PubMed Web of Science ®Google Scholar
• Hirvikoski T, Waaler E, Alfredsson J, et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behav Res Ther 2011;49(3):175-85
   PubMed Web of Science ®Google Scholar
• Estrada RV, Bosch R, Nogueira M, et al. Psychoeducation for adults with attention deficit hyperactivity disorder vs. cognitive behavioral group therapy: a randomized controlled pilot study. J Nerv Ment Dis 2013;201:894-900
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Stevenson RJ, Whitmont S. A self-directed psychosocial intervention with minimal therapist contact for adults with attention deficit hyperactivity disorder. Clin Psychol Psychother 2003;10:93-101
   Web of Science ®Google Scholar
• Meijer WM, Faber A, van den Ban E, Tobi H. Current issues around the pharmacotherapy of ADHD in children and adults. Pharm World Sci 2009;31:509-16
   PubMed Web of Science ®Google Scholar
• Landaas ET, Johansson S, Jacobsen KK, et al. An international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes Brain Behav 2010;9:449-58
   PubMed Web of Science ®Google Scholar
• ADHD-Europe Declaration about AD/HD. Available from: www.adhdeurope.eu/adhd-europe/adhd-declaration.html
   Google Scholar
• Kessler RC, Green JG, Adler LA, et al. Structure and Diagnosis of Adult Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 2010;67:1168-78
   PubMed Web of Science ®Google Scholar
• Sobanski E, Sabljic D, Alm B, et al. Driving performance in adults with ADHD: results from a randomized, waiting list controlled trial with atomoxetine. Eur Psychiatry 2013;28(6):379-85
   PubMed Web of Science ®Google Scholar
• Huss M, Ginsberg Y, Tvedten T, et al. Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. Adv Ther 2013;1-22
   PubMed Web of Science ®Google Scholar
• Durell TM, Adler LA, Williams DW, et al. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol 2013;33:45-54
   PubMed Web of Science ®Google Scholar
• Retz W, Rösler M, Ose C, et al. Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry 2012;13:48-59
   PubMed Web of Science ®Google Scholar
• Rösler M, Ginsberg Y, Arngrim T, et al. Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate. World J Biol Psychiatry 2011;1-9
   PubMed Web of Science ®Google Scholar